Navigation Links
Rigel Announces Pricing of Public Offering of Common Stock
Date:1/31/2008

SOUTH SAN FRANCISCO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of its public offering of 5,000,000 shares of common stock at a price of $27.00 per share. All of the shares are being offered by Rigel. The underwriters have an option to purchase up to an additional 750,000 shares to cover over-allotments, if any. The offering is expected to close on February 6, 2008, subject to the satisfaction of customary closing conditions.

Credit Suisse Securities (USA) LLC is acting as the sole book-runner for the offering, with Thomas Weisel Partners LLC, Jefferies & Company, Inc. and Oppenheimer & Co. Inc. acting as co-managers.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities. A prospectus supplement relating to these securities will be filed with the Securities and Exchange Commission. This offering of shares of common stock may be made only by means of the prospectus supplement and accompanying prospectus.

Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from Credit Suisse Securities (USA) LLC, Prospectus Department, One Madison Avenue, New York, New York 10010-3629 (Telephone number 1-800-221-1037).

About Rigel (http://www.rigel.com)

We are a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases. Our goal is to file one new investigative new drug application in a significant indication each year. We have achieved this goal each year beginning in 2002.
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rigel to Present at BIO Investor Forum 2007
2. Rigel to Present Research Programs at Scientific Conferences
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...is a research industry first, allowing veterinary ...h safety study data to be managed in one software ...ls, NJ (PRWEB) November 9, 2009 -- Xybion Medical ...ima™ VM, an integrated enterprise software s... and care of veterinary research subjects. Pristim...
(Date:11/6/2009)...l/ - Microbix Biosystems Inc. (the "Company") anno... Certification of Annual Filings of William Gastle...Chief Financial Officer (the "Officer,s Certificat... annual audited financial statements for the year ...lly filed the annual financial statements for the ...
(Date:11/6/2009)...e-FirstCall/ -- ,, 3Q09 Corporate Highlights...Marketing Authorization to Astellas Pharma Europe ...diness activities Expanded management team to inc...ector, Commercial Operations Appointed Bradford S... chairman , Upcoming 2009 Milestones: ,...
(Date:11/5/2009)... , Fuel economy ratings for the new 2010 model y...nomy.gov web site, which Oak Ridge National Labor...ent of Energy and the U.S. Environmental Protectio...fuel economy list are hybrid electrics, led by the...t proves that hybrids have gone mainstream," said ...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...uncement that it plans to buy its former parent A...heir eyes open for new opportunities. , ,Drew Pete...ecom , said the merger between SBC and AT&T is a s...communications rather than a regional one. TDS, wh...western company, is keeping an eye out for any new...
...ed January a notoriously depressing month because...d dank weather thats no surprise. In fact, an Eng... one week ago) was the most depressing day of the ...ar an extra psychological burden because of the ch...calated last month for reasons that have nothing t...
...m Chicago is being welcomed with open arms and ope...nounced earlier this week that Clonex Development... of Commerce Technology Venture Fund (TVF) and ...p the company purchase new equipment and hire prof... enthusiastic to join the dynamic biotechnology en...
Other Biology Technology:SBC merger with AT&T could open opportunities in Wisconsin 2Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4
(Date:11/6/2009)...ts generally live in harmony with their arboreal h... out of space in their trees of choice, the ants c...esearch, published in the November issue of the A... ants bore into live trees, and it reopens a centu...nd plants. , Ants and certain species of plants ...
(Date:11/5/2009)...Researchers at Yale University have developed synt...mune response to HIV and HIV-infected cells, as we...blished online in the Journal of the American Che...proaches for these diseases. , The molecules c... (ARM-H) and "antibody-recruiting molecule targeti...
(Date:11/4/2009)...rridors in the cities of Long Beach and Riverside ...eventable childhood asthma, and the true impact of...as likely been underestimated, according to resear...C). , The study, which appears in an online edi...stimated that nine percent of all childhood asthma...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 1University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 2University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 3University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 4University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 5Media small businesses invited to ACS webinar on green chemistry project financing 58027 1K State geographer working to clarify what sustainability really means to rural decision makers 10035 1K State geographer working to clarify what sustainability really means to rural decision makers 10035 2
...go the Department of Cell Biology and Histology at...search into how cell death was boosted by means of...ld be used in the fight against cancer cells. , ...lk, liver, egg yolk, butter and other foodstuffs a...ange colour, such as carrots and pumpkins. , This...
...-cell boundary where a tumor meets normal tissue i... a new study by scientists at Washington Universit... found that tumor cells bordering normal tissue re...he tumor, allowing the cancer cells to establish d...The researchers say their discovery demonstrates t...
...chers, led by investigators at Washington Universi... a gene variant for a bitter-taste receptor on the...lcohol dependence.The research team studied DNA sa...t three alcoholic individuals. The families are pa...rative Study of the Genetics of Alcoholism (COGA)....
Other Biology News:Retinol for combating leukemia cells 2Retinol for combating leukemia cells 3Tumor cells that border normal tissue are told to leave 2Tumor cells that border normal tissue are told to leave 3Variation in bitter-taste receptor gene increases risk for alcoholism 2
Rat Leptin from Cell Sciences
Lentiviral Vector Manufacture from Lentigen
Chicken IgG ELISA Kit from Bethyl Laboratories
Cat IgM ELISA Kit from Bethyl Laboratories
Biology Products: